Commentary: Radiofrequency ablation for colorectal liver metastases: do not blame the biology when it is the technology

American Journal of Surgery

Volumn 197, Issue 6, 2009, Pages 737-739

  Abdalla, Eddie K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER SURVIVAL; COLORECTAL CANCER; LIVER METASTASIS; LIVER RESECTION; MEDICAL TECHNOLOGY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; TUMOR LOCALIZATION; TUMOR VOLUME;

BIOLOGY; CATHETER ABLATION; COLORECTAL NEOPLASMS; HUMANS; LIVER NEOPLASMS;

EID: 66149136816     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2008.06.029     Document Type: Note

References (22)

1. Hur H., Ko Y.T., Min B.S., et al. Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal metastases. Am J Surg 197 (2009) 728-736
2. Aloia T.A., Vauthey J.N., Loyer E.M., et al. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 141 (2006) 460-467
3. Amersi F.F., McElrath-Garza A., Ahmad A., et al. Long-term survival after radiofrequency ablation of complex unresectable liver tumors. Arch Surg 141 (2006) 581-588
4. Livraghi T., Solbiati L., Meloni F., et al. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach". Cancer 97 (2003) 3027-3035
5. Abdalla E.K., Vauthey J.N., Ellis L.M., et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239 (2004) 818-827
6. Fernandez F.G., Drebin J.A., Linehan D.C., et al. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 240 (2004) 438-450
7. Simon C.J., Dupuy D.E., DiPetrillo T.A., et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 243 (2007) 268-275
8. Zorzi D., Mullen J.T., Abdalla E.K., et al. Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases. J Gastrointest Surg 10 (2006) 86-94
9. Abdalla E.K., Ribero D., Pawlik T.M., et al. Resection of hepatic colorectal metastases involving the caudate lobe: perioperative outcome and survival. J Gastrointest Surg 11 (2007) 66-72
10. Mahvi D.M., and Lee Jr. F.T. Radiofrequency ablation of hepatic malignancies: is heat better than cold?. Ann Surg 230 (1999) 9-11
11. Adam R., Delvart V., Pascal G., et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240 (2004) 644-657
12. Pozzo C., Basso M., Cassano A., et al. Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol 15 (2004) 933-939
13. Blazer D.G., Maru D.M., Abdalla E.K., et al. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol (2008) (in press)
14. Adam R., Wicherts D.A., de Haas R.J., et al. Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality?. J Clin Oncol 26 (2008) 1635-1641
15. Abdalla E.K., Hicks M.E., and Vauthey J.N. Portal vein embolization: rationale, technique and future prospects. Br J Surg 88 (2001) 165-175
16. Azoulay D., Castaing D., Smail A., et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 231 (2000) 480-486
17. Ribero D., Abdalla E.K., Madoff D.C., et al. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 94 (2007) 1386-1394
18. Vauthey J.N., Pawlik T.M., Abdalla E.K., et al. Is extended hepatectomy for hepatobiliary malignancy justified?. Ann Surg 239 (2004) 722-730
19. Chun Y.S., Vauthey J.N., Ribero D., et al. Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. J Gastrointest Surg 11 (2007) 1498-1504
20. Braun M.S., Richman S.D., Quirke P., et al. Predictive biomarkers of chemotherapy efficacy in colorectal cancer: results from the UK MRC FOCUS trial. J Clin Oncol 26 (2008) 2690-2698
21. Khambata-Ford S., Garrett C.R., Meropol N.J., et al. Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab. J Clin Oncol 25 (2007) 3230-3237
22. Halazun K.J., Aldoori A., Malik H.Z., et al. Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol 34 (2008) 55-60